An update on retinal laser therapy

JH Lock, KCS Fong - Clinical and Experimental Optometry, 2011 - Taylor & Francis
Since its discovery in the 1940s, retinal photocoagulation has evolved immensely. Although
the first photocoagulators used incandescent light, it was the invention of the laser that …

Clinical outcome of retinal vasculitis and predictors for prognosis of ischemic retinal vasculitis

L Sharief, S Lightman, T Blum-Hareuveni, A Bar… - American Journal of …, 2017 - Elsevier
Purpose To determine factors affecting the visual outcome in eyes with retinal vasculitis and
the rate of neovascularization relapse in ischemic vasculitis. Design Retrospective cohort …

Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study

SD Patwardhan, R Azad, BM Shah, Y Sharma - Retina, 2011 - journals.lww.com
Purpose: To investigate the role of intravitreal bevacizumab in Eales disease with dense
vitreous hemorrhage. Methods: This is a prospective randomized control trial. Twenty eyes …

Surgical outcomes for vitrectomy in Eales' disease

D Shukla, S Kanungo, NM Prasad, R Kim - Eye, 2008 - nature.com
Methods This retrospective case series enrolled 63 patients (71 eyes) who underwent pars
plana vitrectomy (PPV) for the complications of Eales' disease. Indications included …

Clinical characteristics of Eales disease and the efficacy of different interventions for neovascular complications

X Zhao, S Cheng, W Zhang, L Meng, Y Chen - Retina, 2022 - journals.lww.com
Purpose: To evaluate clinical features and manifestations of Eales disease and the efficacy
of different interventions. Methods: The databases PubMed, EMBASE, and Ovid from …

[HTML][HTML] Eales Disease

K Raizada, K Tripathy - 2020 - europepmc.org
Objectives: Identify the etiology of Eales disease. Describe the physical findings associated
with the Eales disease. Outline the management considerations for patients with Eales …

[HTML][HTML] Combination of intravitreal bevacizumab and peripheral photocoagulation: an alternative treatment in eales disease

CP Juarez, AL Gramajo, JD Luna - Medical Hypothesis, Discovery …, 2013 - ncbi.nlm.nih.gov
To report the efficacy of combination therapy (bevacizumab and photocoagulation) in a case
of Eales Disease this study has been performed. Bevacizumab (Avastin, 1.25 mg/0.05 ml) …

Pediatric Eales disease: an Indian tertiary eye center experience

PD Majumder, RK Sitaula… - Journal of Pediatric …, 2018 - journals.healio.com
Purpose: To report the clinical profiles, etiologies, treatment modalities, and outcomes for
Eales disease in patients younger than age 16 years in India. Methods: Retrospective …

The use of a vascular endothelial growth factor inhibitor (ranibizumab) in macular edema due to eales disease

SR Gupta, CJ Flaxel - Retinal Cases and Brief Reports, 2012 - journals.lww.com
Purpose: To report the results of intravitreal use of ranibizumab in a patient with macular
edema due to Eales disease. Method: This was an open-label, Phase 1, 6-month study of …

Eales' disease: the great masquerader

J Davis, SH Schecter, J Sowka - Optometry-Journal of the American …, 2009 - Elsevier
BACKGROUND: Eales' disease, also known as idiopathic retinal periphlebitis, is a diagnosis
of exclusion, mainly affecting men in the second through fourth decades of life. Although less …